TempraMed Technologies (FRA:9DY) FCF Margin %: -494.75% (As of Mar. 2026)


FRA:9DY TempraMed Technologies Ltd FRA:9DY
10 GF Score
Price €0.33
! 5 Warning Signs
View Full Analysis

What is TempraMed Technologies FCF Margin %?

TempraMed Technologies FRA:9DY -18.63% 10 FCF Margin % is -494.75% as of Mar. 2026. GuruFocus rates FRA:9DY with a GF Score™ of 10/100. The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, TempraMed Technologies ranks worse than 91.3% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. TempraMed Technologies's Free Cash Flow for the three months ended in Mar. 2026 was €-1.70 Mil. TempraMed Technologies's Revenue for the three months ended in Mar. 2026 was €0.34 Mil. Therefore, TempraMed Technologies's FCF Margin % for the quarter that ended in Mar. 2026 was -494.75%.

As of today, TempraMed Technologies's current FCF Yield % is -13.33%.

The historical rank and industry rank for TempraMed Technologies's FCF Margin % or its related term are showing as below:

FRA:9DY' s FCF Margin % Range Over the Past 10 Years
Min: -370.63   Med: -124.35   Max: -41.57
Current: -370.63

During the past 3 years, the highest FCF Margin % of TempraMed Technologies was -41.57%. The lowest was -370.63%. And the median was -124.35%.

FRA:9DY's FCF Margin % is ranked worse than
91.3% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: -0.22 vs FRA:9DY: -370.63

TempraMed Technologies FCF Margin % Related Terms

TempraMed Technologies FCF Margin % Historical Data

* Premium members only.

The historical data trend for TempraMed Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TempraMed Technologies FCF Margin % Chart

TempraMed Technologies Annual Data
Trend Dec23 Dec24 Dec25
FCF Margin %
0.00 -41.58 -207.05

TempraMed Technologies Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only -218.11 0.00 -341.02 -483.62 -494.75

FRA:9DY vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, TempraMed Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TempraMed Technologies FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TempraMed Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where TempraMed Technologies's FCF Margin % falls into.


FRA:9DY
10GF Score
TempraMed Technologies Ltd FRA:9DY
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TempraMed Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

TempraMed Technologies's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.259/1.574
=-207.05 %

TempraMed Technologies's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.697/0.343
=-494.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -494.75% mean?
TempraMed Technologies (FRA:9DY) has a FCF Margin % of -494.75% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TempraMed Technologies and its competitors. According to the industry distribution chart, TempraMed Technologies ranks #745 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 91.3%.
Is TempraMed Technologies' FCF Margin % too high?
TempraMed Technologies' current FCF Margin % is -494.75%. Based on the distribution chart, TempraMed Technologies ranks #745 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, TempraMed Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TempraMed Technologies ranks #745 out of 816 companies for FCF Margin %. This places TempraMed Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TempraMed Technologies and its competitors. TempraMed Technologies's current FCF Margin % is -494.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current FCF Margin % of -494.75%. The current FCF Margin % is -494.75%. TempraMed Technologies' overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current FCF Margin % is -494.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TempraMed Technologies Business Description

Other Exchanges VIVI:Canada
Address Heh B’Iyar 14, Tel-Aviv, ISR, 6209307
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
10GF Score

Get the complete analysis for FRA:9DY

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.33
Price